About
Daniel Parera, a Munich-based physician-entrepreneur investor with clinical and operational founder experience, specializes in later-stage European life sciences—particularly radiopharmaceuticals and oncology—and bridges German-speaking biotech via his Nuclidium board role.
Invests in
AI & Machine LearningBiotechHealthtechMedical DevicesRobotics
Experience
- Kurma PartnersPartnercurrent2022 — presentMunich, Bavaria, Germany
- Kurma PartnersSenior Advisor2021 — 2022Munich, Bavaria, Germany
- NUCLIDIUM AGMember Board of Directorscurrent2025 — present
- IcanoMABCo-Founder, -CEO & Chief Medical Officer2020 — 2022Bavaria, Germany
- Prothea-X LLCCo-Founder and Chairman2018 — 2021
- New Rhein Healthcare InvestorsExecutive In Residence2020 — 2021Philadelphia, Pennsylvania, United States
- TVM Capital GroupExecutive in Residence2016 — 2020Greater Munich Metropolitan Area
- leon-nanodrugsMember of the Board of Directors2017 — 2019Greater Munich Metropolitan Area
- Mediti Pharma Inc.Observer Board of Directors2017 — 2019Greater Montreal Metropolitan Area
- Centogene AGMember of The Supervisory Board2017 — 2019Berlin Metropolitan Area
- NovartisGlobal Head New Products & Portfolio Strategy Biopharmaceuticals, Sandoz2011 — 2016Greater Munich Metropolitan Area
- NovartisGlobal Head of Development, Diagnostics2009 — 2011San Francisco Bay Area
- NovartisGlobal Franchise Head of Strategic Marketing, Immunology and Infectious Diseases, Pharma2007 — 2009Basel, Switzerland
- NovartisGlobal Head of Marketing Transplantation a.i., Pharma2008Basel, Switzerland
- NovartisVarious positions in Marketing, BD&L, Strategic Planning, Pharma2004 — 2007Basel, Switzerland
- McKinsey & Co., Inc.Engagement Manager2000 — 2004Germany
Education
- Medical School, Johannes-Gutenberg University MainzMD
Skills & more
Strategy20Strategic Planning7Leadership1Board LevelInfectious Diseases25Product Launch4Emerging Markets2Start-ups1Business Development1Commercialization3Biotechnology8Mergers & Acquisitions1
+12 more
ImmunologyHardware DiagnosticsOncologyTransplantCross-functional Team LeadershipVenture CapitalM&A experienceMedical DevicesCorporate DevelopmentDue DiligenceProduct ManagementPharmaceutical IndustryFrom Daniel's professional profile.
Colleagues at Kurma Partners
Alain Horvais
Partner at Kurma Partners
Amanda Gett
Partner at Kurma Partners
Amine Marouf
Principal at Kurma Partners
Anna Tchorzewska
Associate at Kurma Partners
Benjamin Belot
Partner at Kurma Partners
Cyril Bedran
Directeur Financier at Kurma Partners
Fatima Boubnad
Assistante de gestion at Kurma Partners
Florence de Coorebyter
Associate at Kurma Partners
Frequently asked questions
- Where does Daniel Parera work?
- Daniel Parera is Partner at Kurma Partners.
- What does Daniel Parera invest in?
- Daniel Parera invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices, Robotics.
Shared employers
Also worked at Kurma Partners27
Loubaba El AyoubiInvestor at NorthzoneThierry LaugelManaging Partner at Kurma PartnersRémi DrollerManaging Partner at Kurma PartnersPhilippe PeltierPartner at Kurma PartnersAlain HorvaisPartner at Kurma PartnersHadrien BouchezPartner at Kurma Partners
+ 21 more
Also worked at NUCLIDIUM AG2
Also worked at New Rhein Healthcare Investors5
Also worked at Novartis126
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 120 more